| Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 GBDS Collaborators Lancet Neurol, 2021 | 6274* | 2021 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1200 | 2022 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 940 | 2023 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 379 | 2022 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 156 | 2023 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 144 | 2022 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, SH Ghamari, EM Rad, N Rezaei, ... EClinicalMedicine 59, 2023 | 142 | 2023 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 123 | 2022 |
| Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta‐analysis AC Linhares, JA Stupka, A Ciapponi, AE Bardach, D Glujovsky, PK Aruj, ... Reviews in Medical Virology 21 (2), 89-109, 2011 | 123 | 2011 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBD 2021 Anaemia Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 108 | 2023 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 99 | 2024 |
| Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 E Cousin, BB Duncan, C Stein, KL Ong, T Vos, C Abbafati, ... The Lancet diabetes & endocrinology 10 (3), 177-192, 2022 | 89 | 2022 |
| Longitudinal effects of dietary sodium and potassium on blood pressure in adolescent girls JR Buendia, ML Bradlee, SR Daniels, MR Singer, LL Moore JAMA pediatrics 169 (6), 560-568, 2015 | 86 | 2015 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 82 | 2024 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 75 | 2023 |
| Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis L Reveiz, JA Buendía, D Téllez Revista panamericana de salud pública 26, 341-349, 2009 | 64* | 2009 |
| Implications of global pricing policies on access to innovative drugs: the case of trastuzumab in seven Latin American countries A Pichon-Riviere, OU Garay, F Augustovski, C Vallejos, L Huayanay, ... International journal of technology assessment in health care 31 (1-2), 2-11, 2015 | 61 | 2015 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 55 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 53 | 2024 |
| Actitudes, conocimientos y creencias del paciente hipertenso respecto a la medicación antihipertensiva JA Buendía Biomédica 32 (4), 2012 | 49 | 2012 |
Andres F. ZuluagaUniversidad de AntioquiaVerified email at udea.edu.co